Results 231 to 240 of about 276,656 (346)

Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: A pilot randomized controlled study [PDF]

, 1998
Angelo Sangiovanni, Rino Morales, Giancarlo Spinzi, Maria Grazia Rumi, A Casiraghi, Roberto Ceriani, Enrico Colombo, Maurizio Fossati, Alberto Prada, E Tavani, Giorgio Minoli   +10 more
openalex   +1 more source

Combined screening of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in an emergency department: The URDEPTRIO cross‐sectional study

Academic Emergency Medicine, EarlyView.
Chris Wong, Quentin Le Hingrat, Florian Salipante, Vincent Mackiewicz, Florence Damond, Lucile Larrouy, Christophe Choquet, Dan Pospai, Karen Champenois, Diane Descamps, Judith Leblanc, Paul Loubet, Enrique Casalino, Jade Ghosn, Donia Bouzid   +14 more
wiley   +1 more source

Organoid Models to Study Human Infectious Diseases

Cell Proliferation, EarlyView.
Our manuscript reviews the role of organoids as models for studying human infectious diseases, highlighting their irreplaceable contributions to drug testing and vaccine development for significant infectious diseases including HIV, ZIKV, SARS‐CoV‐2 and MPXV.
Sijing Zhu, Dan Chen, Xinzhi Yang, Liuliu Yang, Yuling Han   +4 more
wiley   +1 more source

Identity by descent and local ancestry mapping of HCV spontaneous clearance in populations of diverse ancestries. [PDF]

BMC Genomics
Yu Z, Abdel-Azim S, Duggal P, Vergara C.
europepmc   +1 more source

Conparison of HCV Positive Rate and Biochemical Data in Two AMHTS

, 1994
吉川 治, 松本 幸弘, 鳴戸 真美子, 永倉 由美, 野呂 光子, 伊沢 清, 伊藤 健次郎   +6 more
openalex   +2 more sources

Quantification of hepatitis C virus by TaqMan PCR: Comparison with HCV amplicor monitor assay [PDF]

, 1999
S Kawai, Osamu Yokosuka, Tatsuo Kanda, Fumio Imazeki, Yasushi Maru, Hiromitsu Saisho   +5 more
openalex   +1 more source

Autoimmunity in MASLD: Focus on autoantibodies, anti‐apolipoprotein A1 IgG and G protein‐coupled receptors

European Journal of Clinical Investigation, EarlyView.
This review outlines the potential role of anti‐GPCR autoantibodies in MASLD/MASH, given their involvement in a wide range of diseases and their possible contribution to MASLD/MASH pathophysiology. We also focused on anti‐ApoA1 autoantibodies, sharing functional features with anti‐GPCR autoantibodies and have been shown to promote liver steatosis in ...
Sabrina Pagano, Emmanuel Somm, François R. Jornayvaz, Nicolas Vuilleumier   +3 more
wiley   +1 more source

Outcomes of High Kidney Donor Profile Index Hepatitis C Nucleic Acid Testing Positive Kidneys are Equivalent to Matched Hepatitis C Nucleic Acid Testing Negative Kidneys. [PDF]

Transplant Direct
He S, Thomas CP, Gunderson AE, Ten Eyck P, Reed AI.   +4 more
europepmc   +1 more source

ANTIBODIES TO HEPATITIS C VIRUS (HCV) IN CHRONIC DIALYSIS PATIENTS (CDP)

, 1996
B. Eppinger, R. Ahmad, M. Haddad, M. Ahamd, A. M. Tannenberg   +4 more
openalex   +1 more source

Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns [PDF]

, 1995
Jean‐Michel Pawlotsky, F Roudot-Thoraval, C Pellet, Pascale Aumont, Françoise Darthuy, Jocelyne Rémiré, J Duval, Daniel Dhumeaux   +7 more
openalex   +1 more source